首页 › 基金 › OFI INVEST ASSET MANAGEMENT › MRNA
OFI INVEST ASSET MANAGEMENT 对 MRNA 的持仓历史
Moderna Inc · 医疗保健
OFI INVEST ASSET MANAGEMENT 在 Q3 2026 的 13F 申报中披露持有 MRNA(Moderna Inc)546,380 股,市值约 US$92.6M,约占其申报组合的 0.93%,在其申报持仓中市值排名第 26 位。 OFI INVEST ASSET MANAGEMENT 最近 13 个申报季度中有 11 个季度披露了 MRNA 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-06 · 来源: SEC EDGAR Form 13F-HR
OFI INVEST ASSET MANAGEMENT 对 MRNA 的持仓演变
OFI INVEST ASSET MANAGEMENT 于 Q3 2023 首次披露 MRNA 持仓:1,110 股(约 US$108K)。 该持仓在 Q3 2026 达到峰值 546,380 股,市值约 US$92.6M。 在 11 次申报中,OFI INVEST ASSET MANAGEMENT 2 次增持、2 次减持、6 次保持不变。 最近一期申报(Q3 2026)显示持股 546,380 股、市值约 US$92.6M。 持仓曾出现大幅变动:Q1 2025 减持约 51% (随后一个季度股价下跌 3%)、Q2 2025 减持约 49% (随后一个季度股价下跌 6%)、Q1 2026 增持约 183753% (随后一个季度股价上涨 38%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 1.11K | $108.29K | 新进 |
| Q4 2023 | 1.11K | $99.93K | 持有 |
| Q1 2024 | 1.11K | $109.52K | 持有 |
| Q4 2024 | 1.19K | $47.90K | 增持 |
| Q1 2025 | 582 | $15.28K | 减持 |
| Q2 2025 | 298 | $7.00K | 减持 |
| Q3 2025 | 298 | $6.55K | 持有 |
| Q4 2025 | 298 | $7.48K | 持有 |
| Q1 2026 | 547.88K | $24.16M | 增持 |
| Q2 2026 | 547.88K | $33.56M | 持有 |
| Q3 2026 | 546.38K | $92.63M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MRNA 与 13F 数据
MRNA(Moderna Inc)属于医疗保健行业。我们追踪的基金中还有 37 只申报持有 MRNA,申报仓位最大的包括:Baillie Gifford (US$1.28B), Theleme Partners LLP (US$564.3M), BANQUE PICTET & CIE SA (US$414.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MRNA 的基金
- Baillie Gifford 18.21M 股 · $1.28B · Q2 2026
- Theleme Partners LLP 8.06M 股 · $564.27M · Q2 2026
- BANQUE PICTET & CIE SA 2.15M 股 · $414.27M · Q3 2026
- Flagship Pioneering, LLC 4.63M 股 · $324.39M · Q2 2026
- Douglas Lane & Associates, LLC 1.16M 股 · $223.56M · Q3 2026
- Beau Ventures, LLc 1.00M 股 · $192.58M · Q3 2026
- Merck & Co., Inc. 2.31M 股 · $161.64M · Q2 2026
- Baron 基金 1.99M 股 · $139.32M · Q2 2026
- BAMCO INC /NY/ 1.99M 股 · $139.32M · Q2 2026
- IMC-Chicago, LLC 1.70M 股 · $119.21M · Q2 2026
更多关于 OFI INVEST ASSET MANAGEMENT
常见问题
How long has OFI INVEST ASSET MANAGEMENT held MRNA?
OFI INVEST ASSET MANAGEMENT has disclosed MRNA holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
What is OFI INVEST ASSET MANAGEMENT's current position in MRNA?
As of Q3 2026, OFI INVEST ASSET MANAGEMENT holds 546.38K shares of MRNA (Moderna Inc), valued at $92.63M, representing 0.93% of its reported portfolio and ranking #26.
Has OFI INVEST ASSET MANAGEMENT been buying or selling MRNA?
In the latest 13F filing (Q3 2026), OFI INVEST ASSET MANAGEMENT held unchanged its position in MRNA. The position peaked in Q3 2026 at 546.38K shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include Baillie Gifford, Theleme Partners LLP, BANQUE PICTET & CIE SA, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.